Dr Reddys Laboratories Share Price Today - Live Blog for December 15, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.15% decline, and it currently trades at ₹1,277.40 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd stock price decreased by -0.05%, with the current market value at ₹1,280.35 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,280.45. The stock is currently trading at a PE of 18.6200, while the industry PE is 33.2891, prompting investors to assess its value proposition.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.07% boost, with the current market value at ₹1,281.20 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd share price surged by 0.06%. With its current market price standing at ₹1,280.25 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,280.25 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.06% increase and currently trading at ₹1,280.25 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's stock price surged by 0.02%, reaching the current market value of ₹1,279.50 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.02% upswing and is currently trading at ₹1,279.50, indicating strong market sentiment.

Dr Reddys Laboratories Ltd experienced a -0.04% downturn in its share price, and it's currently trading at ₹1,279.20. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares saw a -0.18% decrease, reaching a current market price of ₹1,279.70. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.6200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.23% upswing and is currently trading at ₹1,281.95, indicating strong market sentiment.

Dr Reddys Laboratories Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,280.00. With the stock's PE at 18.6200 and the industry PE at 33.2891, investors are weighing their options.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.01% boost, with the current market value at ₹1,280.15 per share. This surge has not gone unnoticed by investors.

Following a noteworthy 0.08% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,280.00. When it comes to valuation, this stock has a PE ratio of 18.6200, with the industry PE ratio at 33.2891.

Demonstrating a commendable 0.11% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,279.50. In terms of valuation, the stock maintains a PE ratio of 18.6200, while the industry PE ratio stands at 33.2891.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.24% gain, with the share price now at ₹1,278.00. Notably, the stock's PE ratio stands at 18.6200, and its Return on Equity (ROE) is 16.0277%.

Following a noteworthy 0.16% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,275.00. When it comes to valuation, this stock has a PE ratio of 18.6200, with the industry PE ratio at 33.2891.

The share price of Dr Reddys Laboratories Ltd experienced a -0.08% slump and is currently trading at ₹1,272.00. While the stock maintains a PE ratio of 18.6200, the industry PE is 33.2891, raising questions about valuation.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,273.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,271.40. Investors should examine the factors driving this decline. The stock's PE ratio is 18.6200, whereas the industry PE ratio stands at 33.2891.

Dr Reddys Laboratories Ltd witnessed a notable 0.15% surge in its share price and is presently trading at ₹1,271.20, captivating the attention of market participants.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.28% recently. As of now, this stock is actively trading at a current market price of ₹1,269.30 per share, attracting attention from investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.28% boost, with the current market value at ₹1,269.30 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.09% drop, and it's now trading at ₹1,265.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.22%, a situation worth noting. At present, the stock is trading at ₹1,265.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.6200, while the industry PE ratio is 33.2891.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.02% upswing, and it's currently trading at ₹1,269.30 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's share price rallied by 0.09%, reaching the current market price of ₹1,269.50. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.11% increase and currently trading at ₹1,269.30 per share. This upward trajectory is turning heads in the market.

The stock of Dr Reddys Laboratories Ltd has experienced a -1.04% drop, and it's now trading at ₹1,266.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.